Loading clinical trials...

Assessing a Length Artificial Intelligence Algorithm to Estimate Length of Children | Clinical Trials | Clareo Health

COMPLETED

Assessing a Length Artificial Intelligence Algorithm to Estimate Length of Children

Assessing the Use of a Growth Artificial Intelligence Algorithm for Estimating the leNgth of Children in Real-world Setting

NCT05079776•Danone Asia Pacific Holdings Pte, Ltd.

View on ClinicalTrials.gov

Summary

An exploratory study to explore the possibility of using computer vision algorithms to estimate a child's length using images taken by a healthcare professional or parents.

Detailed Description

This is an exploratory, observational, pilot study that aims to evaluate the performance of a Length Artificial Intelligence (LAI) algorithm in a real world setting. Images will be collected by parents or healthcare professionals, together with physical length measurements. This data will be used to evaluate the accuracy of the algorithm and to explore potential improvements. Data on the acceptance and experience of the using the algorithm will be collected for improvements.

Eligibility

Age

0 - 1 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Children aged 0 to 18 months old.
•2. Parent(s) should have access to the internet and a smartphone or tablet to complete study questionnaires, take images and upload images.
•3. Parent(s) should be able to comprehend the content of the study and to complete the study questionnaires in English.
•4. Written consent from parent.

Exclusion Criteria

•1. Parent(s) incapable of completing the study questionnaires and uploading of the images using smart phone or tablet with internet.
•2. Children unable to undergo length measurement (e.g. children with structural abnormalities of the lower limbs or orthopedic conditions such as club foot, hip dysplasia, etc).

Locations (1)

KK Women's and Children's Hospital

Singapore, Singapore

Key Dates

Start Date

November 8, 2021

Primary Completion Date

March 8, 2022

Completion Date

June 20, 2022

Last Updated

July 27, 2022

Enrollment

200

ACTUAL participants

Conditions

Growth; Stunting, Nutritional

Interventions

Physical length measurement

OTHER

The Sugira Muryango Longitudinal & Spillover Study

NCT05405400

Cognitive ChangeGrowth; Stunting, Nutritional+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 27, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions